Combination chemotherapy with cyclophosphamide (NSC-26 271) , methotrexate (NSC-740) , and prednisolone (NSC-9 900) (CMP protocol) , for metastatic breast cancer
Umsawasdi, T.; Nilprabhassorn, P.
Journal of the Medical Association of Thailand 61(3): 158-161
1978
ISSN/ISBN: 0125-2208 PMID: 660008 Document Number: 130869
Document emailed within 1 workday
Related Documents
Raevskiĭ, I.G. 1976: Chemotherapy of inoperable breast cancer with a combination of 5-fluorouracil, methotrexate, vincristine, cyclophosphamide and prednisolone Sovetskaia Meditsina 8: 112-114Umsawasdi, T.; Chainuvati, T.; Hitanant, S.; Nilprabhassorn, P.; Viranuvatti, V. 1976: Combination chemotherapy with 5--fluorouracil, amethopterin (methotrexate) and prednisolone (FAP protocol) in the therapy of cholangiocarcinoma Journal of the Medical Association of Thailand 59(8): 380-383
Uzuka, Y.; Saito, Y.; Takahashi, H.; Komatsu, M.; Ito, T. 1989: Combination chemotherapy of multiple myeloma--BCNU.cyclophosphamide.procarbazine.prednisolone and MCNU.cyclophosphamide.procarbazine.prednisolone therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(6): 2269-2273
Burghouts, J.T. 1990: Mitoxantrone, methotrexate and chlorambucil in metastatic breast cancer, a combination with relatively low subjective toxicity Netherlands Journal of Medicine 36(1-2): 43-45
Abeloff, M.D.; Ettinger, D.S. 1977: Treatment of metastatic breast cancer with adriamycin-cyclophosphamide induction followed by alternating combination therapy Cancer Treatment Reports 61(9): 1685-1689
Katsumata, K.; Yamamoto, K.; Shibata, K.; Murano, A.; Kawasaki, M.; Moriwaki, R.; Nagakawa, Y.; Ogata, T.; Koyanagi, Y.; Kusama, M. 1997: Efficacy of combination chemotherapy with mitoxantrone, vincristine, doxifluridine and prednisolone for recurrence of breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(15): 2227-2232
Closon, M.T.; Verbeke, L.; Kains, J.P.; Tijtgat, J.; Schallier, D. 1995: Combination chemotherapy with carboplatin, cyclophosphamide and fluorouracil in advanced breast cancer Anticancer Research 15(2): 591-595
Abe, O.; Izuo, M.; Enomoto, K.; Kubo, K.; Koyama, H.; Sakai, K.; Terasawa, T.; Tominaga, T.; Nomura, Y. 1982: Combination chemotherapy of cyclophosphamide adriamycin and 5-fluorouracil (CAF) in advanced and recurrent breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(5): 866-873
Raina, V.; Sharma, A.; Deo, S.V.; Shukla, N.K.; Mohanty, B.K.; Goel, A.; Rath, G.K. 1998: Mitoxantrone, mitomycin-C, methotrexate combination chemotherapy with radiotherapy and/or surgery in stage IIi (T4B, NO-2, M0) breast cancer Journal of the Association of Physicians of India 46(11): 926-929
Cadman, E.C.; Glick, J.H.; Cross, J.; Horton, J.; Taylor, S.G. 1984: Sequential methotrexate and 5-FU in CMFP (cyclophosphamide, methotrexate, 5-FU, and prednisone) therapy for breast cancer Cancer Treatment Reports 68(6): 877-879
Chen, T.L.; Passos-Coelho, J.L.; Noe, D.A.; Kennedy, M.J.; Black, K.C.; Colvin, O.M.; Grochow, L.B. 1995: Nonlinear pharmacokinetics of cyclophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation Cancer Research 55(4): 810-816
Vogel, C.L. 1995: Combination chemotherapy with vinorelbine (Navelbine) and mitoxantrone for metastatic breast cancer: a review Seminars in Oncology 22(2 Suppl 5: 61-65
Iba, T.; Kidokoro, A.; Fukunaga, M.; Sugiyama, K.; Aihara, N.; Suda, M. 2001: The efficacy of combination chemotherapy of 5'-deoxy-5-fluorouridine (5'-DFUR), cyclophosphamide (CPA) and medroxyprogesterone acetate (MPA) for bone metastasis in breast cancer patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(7): 973-977
Shinagawa, K.; Ogawa, M.; Horikoshi, N.; Inoue, K.; Mukaiyama, T.; Fukutani, H.; Tabata, M.; Hirano, A.; Mizunuma, N. 1989: A study of complete responders in cases of metastatic breast cancer treated with combination chemotherapy Gan no Rinsho. Japan Journal of Cancer Clinics 35(5): 581-586
Cagayan, M.S.F.S. 2012: High-risk metastatic gestational trophoblastic neoplasia. Primary management with EMA-CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy Journal of Reproductive Medicine 57(5-6): 231-236
Pasmantier, M.W.; Coleman, M.; Silver, R.T.; Ballard, W.P. 1985: Six-drug chemotherapy (hexamethylmelamine, doxorubicin, cisplatin, cyclophosphamide, methotrexate, and 5-FU; CHAMP-5) for ovarian carcinoma: alternating sequences of combination regimens Cancer Treatment Reports 69(6): 689-693
Sismondi, P.; Zola, P.; Galletto, L.; De Giovanni, D.; Giardina, G. 1979: Evaluation of the toxicity of precautional chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in carcinoma of the breast in the first 700 treatment cycles Minerva Ginecologica 31(7-8): 563-568
Halim, A.; Wahba, H. 2012: Cisplatin-ifosfamide combination chemotherapy in metastatic triple-negative, anthracycline- and taxane-pretreated breast cancer patients; a phase II study Journal of BUON: Official Journal of the Balkan Union of Oncology 17(2): 254-258
Muthalib, A.; Darwis, I.; Prayogo, N.; Sutjipto 2000: Preliminary results of multicenter phase Ii trial of docetaxel (Taxotere) in combination with doxorubicin as first line chemotherapy in Indonesian patients with advanced or metastatic breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 498-504
Jones, A.L.; Holborn, J.; Ashley, S.; Smith, I.E. 1991: Effective new low toxicity chemotherapy with carboplatin, vinblastine and methotrexate for small cell lung cancer: a randomised trial against doxorubicin, cyclophosphamide and etoposide European Journal of Cancer 27(7): 866-870